Skip to content

Novel hemostatic dressing

Novel nanotechnology-based hemostatic dressing; A proof-of-concept clinical trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202008851772042
Enrollment
30
Registered
2020-08-31
Start date
2020-08-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematological Disorders Injury, Occupational Diseases, Poisoning

Interventions

Novel hemostatic device used to control bleeding during surgical operations.
normal surgical gauze or electric cautery to control bleeding during operation

Sponsors

Prof. Mostafa Hamad
Lead Sponsor
EgyNano Pharma Company
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients undergoing different surgery that may lead to bleeding during the steps of the operation. patients with bleeding severity either moderate or severe according to the mentioned severity score.

Exclusion criteria

Exclusion criteria: Patients with bleeding disorders. Patients with intra-operative disorders that dictate quick completion of the procedure, as severe hypotension, hypo-oxygenation etc. patients with bleeding severity either mild or torrential according to the mentioned severity score.

Design outcomes

Primary

MeasureTime frame
The grade of hemostatic efficacy of the test device application in comparison to normal gauze compression

Secondary

MeasureTime frame
The related complications of the test device application, whether intra-operative or post-operative.

Countries

Egypt

Contacts

Public ContactTahra Sherif

Assiut University

tahrasherif@yahoo.com+201227446166

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026